Predominance of high-grade pathway in breast cancer development of Middle East women
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 18 (7) , 891-897
- https://doi.org/10.1038/modpathol.3800408
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Tissue microarrays in drug discoveryNature Reviews Drug Discovery, 2003
- Gene expression predictors of breast cancer outcomesThe Lancet, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Hereditary breast and ovarian cancer in Asia: genetic epidemiology ofBRCA1 andBRCA2Human Mutation, 2002
- Expression profiling predicts outcome in breast cancerBreast Cancer Research, 2002
- High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence populationBritish Journal of Cancer, 1996
- Novel pattern of P53 mutation in breast cancers from Austrian women.Journal of Clinical Investigation, 1995
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991